NEW YORK (GenomeWeb) – An assay from Quidel to detect and differentiate respiratory syncytial virus and human metapneumovirus has received marketing clearance from the US Food and Drug Administration.

The Solana RSV + hMPV assay detects viral RNA from nasal and nasopharyngeal swabs and runs on the firm's Solana molecular testing instrument. It requires no upfront extraction of RNA and generates an accurate result in approximately 45 minutes, according to the firm.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Nov
15

This webinar will discuss how Amyris, a biotechnology company that develops renewable products for a broad range of applications and industries, uses large-scale microbial engineering to support its manufacturing processes.

Dec
03
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.

Dec
12

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.